Economic evaluation of the impact of medication errors reported by u.s. clinical pharmacists

Pharmacotherapy

Volumn 34, Issue 4, 2014, Pages 350-357

  Samp, Jennifer C ^a   Touchette, Daniel R ^a,b   Marinac, Jacqueline S ^b   Kuo, Grace M ^c,d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b American College of Clinical Pharmacy   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

costs; decision analysis; medication errors; modeling

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE MANAGEMENT; HOSPITALIZATION COST; HUMAN; MEDICATION ERROR; MEDICATION THERAPY MANAGEMENT; MONTE CARLO METHOD; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT REFERRAL; PATIENT SAFETY; PHARMACIST; RISK REDUCTION; UNITED STATES; COST; ECONOMICS; HOSPITALIZATION; INCIDENCE;

COSTS AND COST ANALYSIS; HOSPITALIZATION; HUMANS; INCIDENCE; MEDICATION ERRORS; MONTE CARLO METHOD; PHARMACISTS;

EID: 84898841249     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1002/phar.1370     Document Type: Article

References (19)

1. Nebeker JR, Barach P, Samore MH,. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795-801.
2. Aspden P, Wolcott J, Bootman J, Cronenwett L, eds. Preventing medication errors: quality chasm series. Washington, DC: The National Academies Press; 2007.
3. Kohn LT, Corrigan JM, Donaldson MS,. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.
4. Johnson JA, Bootman JL,. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995; 155: 1949-56.
5. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307-11.
6. Field TS, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH,. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care 2005; 43: 1171-6.
7. Cardarelli R, Mann C, Fulda KG, Balyakina E, Espinoza A, Lurie S,. Improving accuracy of medication identification in an older population using a medication bottle color symbol label system. BMC Fam Pract 2011; 12: 142.
8. Devine EB, Hansen RN, Wilson-Norton JL, et al. The impact of computerized provider order entry on medication errors in a multispecialty group practice. J Am Med Inform Assoc 2010; 17: 78-84.
9. Lapane KL, Waring ME, Schneider KL, Dubé C, Quilliam BJ,. A mixed method study of the merits of e-prescribing drug alerts in primary care. J Gen Intern Med 2008; 23: 442-6.
10. Mitzner TL, Boron JB, Fausset CB, et al. Older Adults Talk Technology: Technology Usage and Attitudes. Comput Human Behav 2010; 26: 1710-21.
11. Kuo G, Touchette D, Marinac J,. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study. Pharmacotherapy 2013; 33: 253-65.
12. Centers for Medicare & Medicaid Services. Fee schedules-general information. 2012. Available from http://www.cms.gov/Medicare/Medicare-Fee-for- Service-Payment/FeeScheduleGenInfo/index.html?redirect=/FeeScheduleGenInfo/. Accessed July 29, 2012.
13. Statistics USBoL. Consumer price index latest numbers. 2012.
14. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ,. Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 1985; 5: 157-77.
15. Gage BF, Cardinalli AB, Albers GW, Owens DK,. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 1995; 274: 1839-45.
16. O'Brien CL, Gage BF,. Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation. JAMA 2005; 293: 699-706.
17. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF,. Lifetime cost of stroke in the United States. Stroke 1996; 27: 1459-66.
18. Elixhauser A, Owens P,. Adverse drug events in U.S. Hospitals, 2004. Rockville, MD: Agency for Healthcare Research and Quality; April 2007; HCUP Statistical Brief #29. Available from http://www/hcup-us.ahrq.gov/reports/ statbriefs/sb29.pdf. Accessed June 20, 2012.
19. Healthcare Cost and Utilization Project (HCUP). Section 4. Costs for Inpatient Hospital Stays. 2012. Available from http://www.hcup-us.ahrq.gov/ reports/factsandfigures/2009/section4-TOC.jsp. Accessed March 13, 2012.